Cita APA (7a ed.)

D, E., & M, S. (2017). Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: A focus on ribociclib. Dove Medical Press.

Cita Chicago Style (17a ed.)

D, Edessa, y Sisay M. Recent Advances of Cyclin-dependent Kinases as Potential Therapeutic Targets in HR+/HER2− Metastatic Breast Cancer: A Focus on Ribociclib. Dove Medical Press, 2017.

Cita MLA (8a ed.)

D, Edessa, y Sisay M. Recent Advances of Cyclin-dependent Kinases as Potential Therapeutic Targets in HR+/HER2− Metastatic Breast Cancer: A Focus on Ribociclib. Dove Medical Press, 2017.